JAMA Internal Medicine 2014-05-05, Author Interview
Interview with Karen Smith-McCune, MD, PhD, author of Choosing a Screening Method for Cervical Cancer: Papanicolaou Testing Alone or With Human Papillomavirus Testing, and Sarah Feldman, MD, MPH, author of Can the New Cervical Cancer Screening and Management Guidelines Be Simplified?
(Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 5, 2014 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Choosing a Screening Method for Cervical Cancer: Papanicolaou Testing Alone or With Human Papillomavirus Testing, and Can the New Cervical Cancer Screening and Management Guidelines Be Simplified?
Interview with Karen Smith-McCune, MD, PhD, author of Choosing a Screening Method for Cervical Cancer: Papanicolaou Testing Alone or With Human Papillomavirus Testing, and Sarah Feldman, MD, MPH, author of Can the New Cervical Cancer Screening and Management Guidelines Be Simplified? (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 5, 2014 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
The Lancet: October 05, 2007
Human papillomavirus DNA testing detects lesions which lead to cervical cancer earlier than conventional cytological techniques, and this early detection could lead to the extension of the current screening interval of five years by at least another year, comments Chris Meijer from VU Medical Centre, Amsterdam in this week's podcast. This extension would be advantageous to women because of a reduction in the lifetime number of screening tests and referrals. An accompanying Comment says that as well as being safe, such extended screening intervals will not only reduce the cost of screening and the burden for women, but ...
Source: Listen to The Lancet - October 5, 2007 Category: Journals (General) Authors: The Lancet Source Type: podcasts
